FDA Greenlights Juul's Tobacco and Menthol E-Cigs Amidst Controversy Over Youth Vaping

July 17, 2025
FDA Greenlights Juul's Tobacco and Menthol E-Cigs Amidst Controversy Over Youth Vaping
  • The FDA has authorized Juul to continue selling its tobacco and menthol-flavored e-cigarettes after a lengthy review process, marking a significant development for the company.

  • Regulators determined that Juul's products are less harmful for adult smokers who switch completely from traditional cigarettes to vaping.

  • This decision comes after years of regulatory limbo, during which Juul's original product, nearly a decade old, faced restrictions and lawsuits.

  • Juul's CEO, K.C. Crosthwaite, highlighted the importance of this decision, emphasizing the scientific support for menthol's role in e-vapor and the company's plans to seek approval for new devices and flavors.

  • Juul aims to gain authorization for its next-generation device and potentially introduce more flavors in the future, despite the current focus on tobacco and menthol options.

  • The FDA's decision follows Juul's earlier discontinuation of several popular flavors, including fruit and candy, which appealed to teenagers.

  • While marketed as an alternative to traditional cigarettes, Juul's products still contain nicotine, which is addictive and associated with health risks like lung and heart disease.

  • Critics, including the Campaign for Tobacco-Free Kids, view the decision as a step backward, linking Juul to the youth vaping crisis and opposing the regulatory approval.

  • Yolonda Richardson and other critics argue that this approval could reverse progress made in reducing underage vaping, despite the regulatory stance that Juul's products are less harmful for adults.

  • The decision has faced widespread opposition from parents, politicians, and anti-tobacco advocates who call for a permanent ban on Juul due to its association with increased youth vaping.

  • Many opponents see this move as a setback in efforts to curb underage vaping, which remains a significant public health concern, with over 1.6 million students reported as users in 2024.

  • Juul's CEO expressed support for the FDA's decision, emphasizing the scientific basis for menthol's role and the importance of a reliable market for smokefree nicotine products.

Summary based on 14 sources


Get a daily email with more US News stories

More Stories